MapLight Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

MapLight Therapeutics (Nasdaq: MPLT) said members of management will participate in three investor conferences in March 2026: Jefferies Biotech on the Beach (March 10), Leerink Global Healthcare (March 11) and Stifel Virtual CNS Forum (March 18).

Where available, live webcasts and archived recordings will be posted on the company’s Events & Presentations page at the investor website.

News Market Reaction – MPLT

+1.91%

1 alert

+1.91% News Effect

+2.8% Peak Tracked

+$15M Valuation Impact

$807M Market Cap

0.5x Rel. Volume

On the day this news was published, MPLT gained 1.91%, reflecting a mild positive market reaction. Argus tracked a peak move of +2.8% during that session. This price movement added approximately $15M to the company's valuation, bringing the market cap to $807M at that time.

Data tracked by StockTitan Argus on the day of publication.

SAN FRANCISCO and BOSTON, March 02, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conferences:

Event: Jefferies 2026 Biotech on the Beach Summit (Miami, FL)
Date: Tuesday, March 10^th
Format: Hosting 1x1 meetings

Event: Leerink 2026 Global Healthcare Conference (Miami, FL)
Date: Wednesday, March 11^th
Format: Presenting and hosting 1x1 meetings

Event: Stifel 2026 Virtual CNS Forum
Date: Wednesday, March 18^th
Format: Presenting and hosting 1x1 meetings

Where available, access to the live webcasts of these events, as well as archived recordings, will be posted under the “Events & Presentations” page on the Investor section of the company’s website at https://ir.maplightrx.com/news-events/events-presentations.

About MapLight Therapeutics

MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. The company was founded by globally recognized leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The company’s discovery platform holds the potential to fill this void by identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. 

For more information, please visit www.maplightrx.com.

For investor inquiries: investors@maplightrx.com

For media inquiries: media@maplightrx.com

FAQ

When will MapLight Therapeutics (MPLT) present at Jefferies Biotech on the Beach 2026?

MapLight management will host one-on-one meetings at Jefferies on March 10, 2026. According to MapLight, access to any available live webcast or archived recording will be posted on the company’s Events & Presentations investor page.

What will MapLight Therapeutics (MPLT) do at the Leerink 2026 Global Healthcare Conference on March 11, 2026?

MapLight will present and host one-on-one meetings on March 11, 2026. According to MapLight, investors can view live webcasts and archived recordings via the company’s Events & Presentations page when available.

How can investors watch MapLight Therapeutics (MPLT) at the Stifel 2026 Virtual CNS Forum on March 18, 2026?

MapLight will present and host one-on-one meetings at the Stifel Virtual CNS Forum on March 18, 2026. According to MapLight, any webcast or archived recording will be posted on the investor Events & Presentations webpage.

Where will MapLight Therapeutics (MPLT) post webcasts and recordings from the March 2026 conferences?

MapLight will post live webcasts and archived recordings on its Events & Presentations investor page. According to MapLight, availability depends on each conference and will be updated on the company website.

Which MapLight Therapeutics (MPLT) management activities are scheduled for March 10–18, 2026?

Management will host one-on-one meetings and deliver presentations across three conferences between March 10–18, 2026. According to MapLight, schedules and any available webcasts will be posted on the Events & Presentations investor page.